Clinical Frailty Scale (CFS)
Also known as: CFS, Frailty Scale, Clinical Frailty Assessment
The Clinical Frailty Scale (CFS), developed by Kenneth Rockwood and colleagues in 2005, is a brief, validated tool for assessing frailty in older adults. Frailty—a syndrome of diminished physiologic reserve, increased vulnerability, and reduced functional ability—is recognized as a distinct clinical state that predicts mortality, disability, and healthcare utilization independent of age and comorbidities. The CFS uses a seven-point (or nine-point in later versions) clinical judgment-based scale, making it practical and rapid for bedside use in hospitals, clinics, and long-term care.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Administer the CFS to older adults (typically ≥65 years) in acute hospitals, emergency departments, primary care clinics, specialty clinics, long-term care facilities, and rehabilitation settings. The scale is particularly useful in: geriatric assessment, preoperative risk stratification, intensive care triage decisions, advance care planning discussions, and research on aging and health outcomes. A single frailty assessment at baseline provides prognostic information and guides treatment intensity and goals of care.
Strengths & limitations
- Rapid and practical—scored in 2–5 minutes based on clinical judgment; requires no special equipment, tools, or calculations; suitable for busy clinical settings.
- Strong predictive validity—CFS score predicts mortality, hospitalization, nursing home placement, and functional decline independent of age, comorbidities, and disability.
- Synthesis of multiple dimensions—incorporates functional status, comorbidity burden, cognitive status, and overall resilience into a single comprehensive score.
- Clinician judgment-based—leverages clinician expertise and intuition, capturing nuanced aspects of vulnerability not captured by tick-box scales.
- Validated globally—extensively studied in diverse settings and populations, with translations and adaptations worldwide.
- Subjective assessment—relies on clinician judgment and may show inter-rater variability; training and calibration improve consistency.
- Does not measure mechanisms—the CFS identifies frailty but does not specify underlying causes (sarcopenia, cognitive impairment, malnutrition) or guide targeted interventions.
- Limited sensitivity at extremes—does not discriminate well among very fit (CFS 1–2) or severely frail (CFS 7) patients.
- Requires clinical experience—accurate scoring depends on clinician familiarity with frailty phenotype and aging; less experienced clinicians may struggle with discrimination.
- No formal diagnostic criteria—frailty definition remains operationalized through this and other scales; clinical consensus on cutoffs varies.
Frequently asked
Does a high CFS score mean the patient will die soon?
High CFS scores (6–7) predict increased mortality risk and shorter life expectancy compared to robust patients, but individual prognosis varies widely. Other factors (acute illness, specific diagnoses, patient goals) also influence survival. Use CFS as one component of prognostic assessment; discuss prognosis, goals, and preferences explicitly with patients and families.
Can a frail patient's CFS score improve?
Yes. Frailty is not irreversible. Improvements may occur with treatment of reversible conditions (anemia, hypothyroidism, depression), increased physical activity, nutritional support, and rehabilitation. Reassess periodically (every 3–6 months or after significant intervention) to capture improvement or deterioration.
My patient is cognitively intact but has multiple comorbidities. Is she frail?
Not necessarily. Having comorbidities does not automatically indicate frailty. Frailty involves diminished physiologic reserve and vulnerability—the ability to withstand stressors. A cognitively intact older adult with controlled diabetes, hypertension, and arthritis but preserved function and no recent decline may score CFS 3–4 (managing well to vulnerable) rather than frankly frail.
Should I use CFS to limit treatment in older frail patients?
CFS score should inform shared decision-making and realistic goal-setting, not automatically restrict treatment. Discuss frailty, prognosis, and the patient's own goals and values. Some frail patients benefit from targeted interventions; others prioritize comfort and quality of life. Decisions should be individualized and collaborative, not driven by a single score.
Sources
- Rockwood, K., Song, X., MacKnight, C., et al. (2005). A global clinical measure of fitness and frailty in elderly people. CMAJ, 173(5), 489-495. DOI: 10.1503/cmaj.050051 ↗
- Rockwood, K., Andrew, M., & Mitnitski, A. (2007). A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci, 62(7), 738-743. DOI: 10.1093/gerona/62.7.738 ↗
How to cite this page
ScholarGate. (2026, June 3). Clinical Frailty Scale (CFS). ScholarGate. https://scholargate.app/en/nursing/clinical-frailty-scale
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Katz Index of Independence in ADLNursing↔ compare
- Waterlow Pressure Injury Risk AssessmentNursing↔ compare
- Zarit Caregiver Burden InterviewNursing↔ compare